Cargando…
Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine
According to the cancer stem cell (CSC) hypothesis, the aggressive growth and early metastasis of pancreatic ductal adenocarcinoma (PDA) is due to the activity of CSCs, which are not targeted by current therapies. Otto Warburg suggested that the growth of cancer cells is driven by a high glucose met...
Autores principales: | Isayev, Orkhan, Rausch, Vanessa, Bauer, Nathalie, Liu, Li, Fan, Pei, Zhang, Yiyao, Gladkich, Jury, Nwaeburu, Clifford C., Mattern, Jürgen, Mollenhauer, Martin, Rückert, Felix, Zach, Sebastian, Haberkorn, Uwe, Gross, Wolfgang, Schönsiegel, Frank, Bazhin, Alexandr V., Herr, Ingrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148131/ https://www.ncbi.nlm.nih.gov/pubmed/25015789 |
Ejemplares similares
-
The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer
por: Hage, C, et al.
Publicado: (2013) -
Sulforaphane counteracts aggressiveness of pancreatic cancer driven by
dysregulated Cx43-mediated gap junctional intercellular communication
por: Forster, Tobias, et al.
Publicado: (2014) -
Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer
por: Zhang, Yiyao, et al.
Publicado: (2015) -
Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cells
por: LABSCH, SABRINA, et al.
Publicado: (2014) -
CD96 as a Potential Immune Regulator in Cancers
por: Feng, Shikai, et al.
Publicado: (2023)